{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T05:51:58Z","timestamp":1792389118745,"version":"4.4.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","geriatriconcology.net","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jgo.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T19:43:00Z","timestamp":1539546180000},"page":"356-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor"],"prefix":"10.1016","volume":"10","author":[{"given":"Lorenzo","family":"Dottorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Di Menna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Marte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bajetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2018.10.007_bb0005","series-title":"I numeri del cancro in Italia","author":"AIOM-AIRTUM","year":"2017"},{"issue":"2","key":"10.1016\/j.jgo.2018.10.007_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for menopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2018.10.007_bb0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.2016.69.2871","volume":"35","author":"Smith","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2018.10.007_bb0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1470-2045(18)30116-5","article-title":"Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA- GIM3): a randomised, phase 3 trial","volume":"19","author":"De Placido","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<395::AID-CNCR24>3.0.CO;2-W","article-title":"Validation of a multidimensional evaluation scale for use in elderly cancer patients","volume":"77","author":"Monfardini","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2018.10.007_bb0030","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.jgo.2018.10.007_bb0035","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment aand manaagemeent of vulnerabilities in older patients receiving chemotherapy: asco guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jgo.2015.02.005","article-title":"Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)","volume":"6","author":"Luciani","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0045","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2013.08.003","article-title":"Accuracy of the G-8geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study","volume":"5","author":"Liuu","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.2013.51.1345","article-title":"Performance of two geriatric screening tools in older patients with cancer","volume":"32","author":"Kenis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2018.10.007_bb0060","article-title":"Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study","volume":"11","author":"Soubeyran","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818302662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818302662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T20:52:40Z","timestamp":1551905560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406818302662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1879406818302662"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2018.10.007","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}